Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption

Biochem Biophys Res Commun. 1999 Jan 8;254(1):248-52. doi: 10.1006/bbrc.1998.9785.

Abstract

We provide the first molecular evidence for the presence of a functional serine/threonine phosphatase, calcineurin-A (CN-A), in the osteoclast. Polymerase chain reaction (PCR) of an osteoclast cDNA library, together with restriction mapping, revealed two isoform sequences, alpha and beta. We then examined the functionality of the detected CN-A by assessing the effect of a classical antagonist, cyclosporin A (CsA), in the osteoclast resorption (pit) assay. CsA (0.1 and 1 microg ml-1) potently inhibited bone resorption. The presence of lymphocytes, with or without prior exposure to CsA in vivo, failed to reverse the CsA-induced resorption-inhibition. Expectedly, CsA had no direct effect on cytosolic Ca2+ levels in fura-2-loaded osteoclasts. These studies are a prelude to further investigations into the possible role of CN-A in osteoclast regulation. Finally, mechanistic studies on the bone effects of CsA, a widely used immunosupressant, should proceed from these observations.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Resorption*
  • Calcineurin / biosynthesis*
  • Calcineurin / genetics
  • Calcineurin Inhibitors
  • Cyclosporine / metabolism*
  • Cyclosporine / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Mice
  • Osteoclasts / metabolism*
  • Protein Isoforms / biosynthesis
  • Protein Isoforms / genetics
  • Rats

Substances

  • Calcineurin Inhibitors
  • Enzyme Inhibitors
  • Protein Isoforms
  • Cyclosporine
  • Calcineurin